Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-02-04
1995-04-25
Tsang, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514255, 544295, 544358, 544360, 544364, 544369, 544374, 544379, 544392, 544398, 544401, 544405, A61K 31495, A61K 3150, C07D40300, C07D40100
Patent
active
054099315
ABSTRACT:
1,3-Substituted cycloalkenes and cycloalkanes are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as dopaminergic, antipsychotic, and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.
REFERENCES:
patent: 4597921 (1990-09-01), Caprathe et al.
patent: 4975445 (1990-12-01), Caprathe et al.
patent: 5124332 (1992-06-01), Wise et al.
Caprathe Bradley W.
Downing Dennis M.
Jaen Juan C.
Johnson Stephen J.
Smith, III William J.
Tinney Francis J.
Tsang Cecilia
Warner-Lambert & Company
LandOfFree
1,3-substituted cycloalkenes and cycloalkanes as central nervous does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,3-substituted cycloalkenes and cycloalkanes as central nervous, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3-substituted cycloalkenes and cycloalkanes as central nervous will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1567952